Troluce Capital Advisors’s TScan Therapeutics TCRX Stock Holding History

Troluce Capital Advisors’s Portfolio TCRX Stock Details TCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell
2025 Q2	$218K	Buy
2025 Q1	$116K	Buy
2024 Q4	$161K	Hold
2024 Q3	$264K	Sell
2024 Q2	$543K	Buy